NASDAQ

Hemab Therapeutics Holdings, Inc. (COAG)

♥ 761 Thanks from members

Live price chart, market sentiment, and community perspectives for Hemab Therapeutics Holdings, Inc. (NASDAQ: COAG).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Hemab Science TeamLeadership: Johan Drejer (CEO)Leadership: Henriette Drachmann (CMO)Holder: Access BiotechnologyHolder: Novo HoldingsHolder: RA Capital ManagementHMAB-101HMAB-201Hemostasis Therapeutics#COAG#Hemab Therapeutics#Biotech Stock#Bleeding Disorders#NASDAQ Healthcare